De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation

Transplantation Proceedings
S MukherjeeD F Schafer

Abstract

Patients with recurrent hepatitis C (HCV) after liver transplantation (OLT) are often treated with interferon and ribavirin in an attempt to eradicate HCV and prevent cirrhosis. We report four patients who developed de novo cryptogenic hepatitis following sustained eradication of recurrent HCV, which led to decompensated liver disease in two patients, both of whom required listing for retransplantation. Between September 2000 and October 2001, 38 consecutive patients with recurrent HCV were treated with interferon alpha 2b and ribavirin, of whom eight patients (21%) developed a sustained response to HCV eradication. Four of these patients developed cryptogenic hepatitis, which led to decompensated cirrhosis in two patients. Both patients were listed for retransplantation but died on the waiting list. No etiology for liver disease was identified despite extensive investigations in all four patients including postmortem analysis in the two patients. We hypothesize that these individuals developed an aberrant immune response leading to allograft injury whose severity may be determined by underlying haplotype, degree of immunosuppression, presence/absence of HCV, and duration of treatment. We have not found any similar reports in t...Continue Reading

References

Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases
May 31, 2001·Journal of Viral Hepatitis·R TeixeiraA K Burroughs
Jun 8, 2001·Transplantation·J P OngB Yen-Lieberman
Sep 5, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E Muñoz de BustilloJ M Morales
Jun 29, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Kozhikode V Narayanan MenonMichael Charlton
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sharon BarrettJohn Crowe
Feb 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Natalia L KomarovaDominik Wodarz
Mar 6, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Marina BerenguerJoaquín Berenguer

❮ Previous
Next ❯

Citations

Jun 8, 2011·Digestive Diseases and Sciences·Albert J Czaja
Jan 30, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Fredric D GordonHugo E Vargas
Nov 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Russell H Wiesner
Mar 21, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Moataz SeyamStefan G Hübscher
Dec 27, 2005·Transplantation·Sandeep Mukherjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.